Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricia Ann Basford is active.

Publication


Featured researches published by Patricia Ann Basford.


International Journal of Pharmaceutics | 2000

Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide

Martyn D. Ticehurst; Patricia Ann Basford; Christopher Ian Dallman; Timothy Michael Lukas; Peter V. Marshall; Gary A. Nichols; David S. Smith

Micronised particles of revatropate hydrobromide were observed to agglomerate when stored in uncontrolled conditions. Dynamic vapour sorption (DVS), isothermal microcalorimetry, microscopy and particle size measurement by laser diffraction have been used to study micronised revatropate hydrobromide. The rate and extent of agglomeration were dependent on the energy of the micronisation process, the sampling point for bulk within the mill and the humidity during storage. The agglomeration was attributed to the recrystallisation of disordered regions on the particles of revatropate hydrobromide generated during micronisation. This recrystallisation was assessed qualitatively and quantitatively, compared against spray-dried amorphous material, using DVS and isothermal microcalorimetry, respectively. A correlation was established between the energy of micronisation and the level of disorder within the micronised powder. A comparison of the DVS profiles of freshly prepared and aged micronised revatropate hydrobromide suggests an increased physical stability for the aged material.


Archive | 2003

Tropane derivatives as ccr5 modulators

Patricia Ann Basford; Peter T. Stephenson; Stefan Colin John Taylor; Anthony Wood


Archive | 2005

Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine

Patricia Ann Basford; Ronald J. Post; Julian Duncan Pfizer Global R D Smith; Geraldine Patricia Taber


Archive | 2001

4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs

Patricia Ann Basford; Paul Blaise Hodgson


Archive | 2011

Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one

Patricia Ann Basford; Anthony Michael Campeta; Adam T. Gillmore; Matthew Cameron Jones; Eleftherios Kougoulos; Suman Luthra; Robert Walton


Archive | 2001

Salt form and polymorphs

Patricia Ann Basford; Paul Blaise Hodgson


Archive | 2011

Salt and polymorph of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one

Patricia Ann Basford; Anthony Michael Campeta; Adam T. Gillmore; Matthew Cameron Jones; Eleftherios Kougoulos; Suman Luthra; Robert Walton; ギルモア アダム; キャムピータ アンソニー; ルースラ スマン; コウゴウロス テリー; バスフォード パトリシア; キャメロン ジョーンズ マシュー; ウォルトン ロバート


Archive | 2011

Sels et polymorphes de la 8-fluoro-2-{4-[(méthylamino}méthyl]phényl}-1,3,4,5-tétrahydro-6h-azépino[5,4,3-cd]indol-6-one

Patricia Ann Basford; Anthony Michael Campeta; Adam T. Gillmore; Matthew Cameron Jones; Eleftherios Kougoulos; Suman Luthra; Robert Walton


Archive | 2011

Sels et polymorphes de 8-fluoro-2-{4-[(méthylamino} méthyl] phényl} -1,3,4,5-tetrahydro-6h-azepino [5,4,3-cd] indol-6-one

Patricia Ann Basford; Anthony Michael Campeta; Adam T. Gillmore; Matthew Cameron Jones; Eleftherios Kougoulos; Suman Luthra; Robert Walton


Archive | 2011

Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one

Patricia Ann Basford; Anthony Michael Campeta; Adam T. Gillmore; Matthew Cameron Jones; Eleftherios Kougoulos; Suman Luthra; Robert Walton

Researchain Logo
Decentralizing Knowledge